KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Enterprise Value: 2009-2024

Historic Enterprise Value for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $385.3 million.

  • Pacira BioSciences' Enterprise Value rose 279.19% to $911.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$512.5 million, marking a year-over-year increase of 33.29%. This contributed to the annual value of $385.3 million for FY2024, which is 70.09% down from last year.
  • Latest data reveals that Pacira BioSciences reported Enterprise Value of $385.3 million as of FY2024, which was down 70.09% from $1.3 billion recorded in FY2023.
  • Pacira BioSciences' Enterprise Value's 5-year high stood at $2.1 billion during FY2020, with a 5-year trough of $385.3 million in FY2024.
  • Moreover, its 3-year median value for Enterprise Value was $1.3 billion (2023), whereas its average is $1.1 billion.
  • In the last 5 years, Pacira BioSciences' Enterprise Value surged by 30.00% in 2020 and then slumped by 70.09% in 2024.
  • Yearly analysis of 5 years shows Pacira BioSciences' Enterprise Value stood at $2.1 billion in 2020, then fell by 2.61% to $2.0 billion in 2021, then declined by 26.73% to $1.5 billion in 2022, then declined by 13.13% to $1.3 billion in 2023, then crashed by 70.09% to $385.3 million in 2024.